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Abstract (Malay Version) 
Pendahuluan. 
Kacip Fatimah ialah sejenis herba tradisional yang mengandungi phytoestrogen. Ia sering 
digunakan oleh orang melayu untuk mengubati penyakit gynekogikal dan sebagai 
rawatan alternatif kepada rawatan hormon. Kegunaan hormon selepas putus haid adalah 
disabitkan dengan peningkatan kepadatan tisu buah dada pada mammogram. Kepadatan 
tisu buah dada pada mammogram merupakan salah satu faktor yang mengakibatkan 
kanser buah dada. 
Tujuan 
Tujuan kajian ini ialah untuk menguji kesan Kacip Fatimah terhadap kepadatan tisu buah 
dada pada mammogram. 
Metodologi 
Satu kajian perspektif telah dijalankan kepada 69 pesakit yang telah dibahagikan kepada 
empat kumpulan iaitu kumpulan 140 mg/hari, 280 mglhari, 560 mglhari dan plasebo. 
Mammogram telah dikaji dan diselidik dengan menggunakan cara skala peratusan, 
klasifikasi BIRAD dan pengukuran berpandukan komputer. 
Keputusan 
Tiada perubahan yang ketara telah direkodkan dengan kajian cara kategorikal seperti cara 
skala peratusan dan klasifikasi BIRAD. Pengukuran berpandukan komputer telah 
menunjukkan penambahan kepadatan tisu buah dada pada mammogram yang kecil antara 
mammogram sebelum rawatan dan selepas rawatan. Penambahan ini adalah tidak ketara 
dari segi statistik. Penambahan kepadatan tisu buah dada pada mammogram selepas 
rawatan berbanding dengan kepadatan tisu buah dada pada mammogram sebelum 
lX 
rawatan adalah 0.2 %, 0.1 o/o, 1.5 % and 0.6 % untuk kumpulan placebo, 140mg , 280mg 
dan 560mg masing-masing. Ini mungkin kerana phytoestrogen adalah sejenis estrogen 
yang lemah. 
Kesimpulan 
Kajian ini menunjuk.kan bahawa Kacip Fatimah tiada kesan terhadap kepadatan tisu buah 
dada pada mammogram. 
X 
Abstract (English Version) 
Introduction 
Kacip Fatimah is a traditional herb that contains phytoestrogen and is commonly used by 
the Malay population in Malaysia to treat various gynecological illnesses. It is also used 
as an alternative to hormone replacement therapy due to its estrogenic effect. 
Postmenopausal hormone use is associated with increase in mammographic density and 
mammographic density is an independent risk factor for breast cancer. 
Objective 
Our purpose was to evaluate the effect of Kacip Fatimah (Labisia pumila) water extract 
on mammographic density in postmenopausal women. 
Material and Method 
A prospective, randomized, double-blind placebo-controlled pilot study was conducted. 
A total of 69 postmenopausal women were equally randomized to receive Kacip Fatimah 
water extract 140 mg/day, 280 mg/day, 560 mg/day or placebo. Mammograms were 
performed at baseline and after 6 months of treatment. Mammographic density was 
evaluated according to percentage scale, BIRAD classification and computer assisted 
measurement of breast density. 
Result 
The categorical assessments showed that there was no significant shift in categorical 
classification as assessed by BIRAD and percentage categories in either control or 
treatment groups. There was slight increase in breast density as assessed by computer 
assisted method although the increases were not statistically significant. The increases in 
breast density over pretreatment baseline were 0.2 °/o, 0.1 %, 1.5 % and 0.6 % for placebo, 
XI 
140 mg group, 280 mg group and 560 mg group, respectively. These values were not 
significantly different from one another. This small increase in breast density might be 
due to the fact that phytoestrogen is a weak estrogen. 
Conclusion 
Kacip Fatimah extract given over a period of 6 months did not significantly affect 
mammographic density. 
Xll 
Introduction 
1.0 Introduction 
Labisia pumila (Kacip Fatimah) is a traditional herb commonly used by Malay women 
during peripartum period to make the process of childbirth easier. It is also used as 
traditional herbal preparation during the postpartum period to improve the general 
condition of mothers. Earlier research on Kacip Fatimah in Institute Medical Research, 
Malaysia showed that it has estrogenic-like activity and behaves like phytoestrogen. 
Menopause is defined as permanent cessation of menstruation resulting from loss of 
ovarian follicular activity. Natural menopause is recognized to have occurred after 12 
consecutive months of amenorrhea for which there is no other obvious pathological or 
physiological cause. Menopausal and perimenopausal issues are important topics 
worldwide and throughout the twentieth century. The life span of women has improved 
significantly in the last two decades. Malaysian women life expectancy now has reached 
76.4 years and for male it was 70.6 years. (Department of statistic Malaysia 2005). 
However, the age of onset of menopause has not changed and remained at 50 to 52 years 
old despite improvement in women's life expectancy. 
Following menopause, there are major changes in androgen, estrogen, and progesterone 
and gonadotrophin secretion due to cessation of ovarian follicular activity. There is 
reduction of circulating androstenedione to approximately 50% of the concentration 
among young women. The Luteinising hormone (LH) and follicular stin1ulating hormone 
(FSH) levels rise substantially with FSH usually higher than LH. As a result of these 
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hormonal changes, postmenopausal women will experience the sequelae of menopause 
like vasomotor symptoms, mood changes, urogenital and sexual changes. 
Hormone replacement therapy (HRT) is commonly prescribed to postmenopausal women 
to improve their postmenopausal symptoms. Kacip Fatimah was claimed to be able to 
alleviate these symptoms as well due to its estrogenic effect. However, prolonged 
administration of hormone replacement therapy has been associated with a slight but 
statistically significant increase in the risk of breast cancer. HRT slows normal breast 
involution and causes an increase in mammographic density. Many studies have 
confirmed that HRT affects mammographic density. Mammographic changes vary with 
different HRT regimens. 
Mammographic density is one of the parameters evaluated in the mammogram and is 
determined by the relative amounts of epithelial tissue, connective tissue and fat in the 
breast. All non fatty breast tissue e.g. epithelial tissue and connective tissue will appear as 
white on mammogram and referred to as mammographic densities. The extent of breast 
density varies widely among women. In general, the breast density decreases with age 
especially after menopause. 
The amount of dense tissue in the breast can be assessed either categorically or 
continuously. Wolfe was the first to describe four categorical patterns of mammographic 
density. BIRAD also divides mammograms into four categories of increasing density. 
-2-
Continuous estimation of the proportion of the breast area that is made up of dense breast 
tissue can be assessed by percent-density methods of evaluating mammographic density. 
Mammographic density is an independent risk factor for breast cancer. The degree of risk 
associated with mammographic density is greater than the degree of risk associated with 
almost all other known breast cancer risk factors. Knowledge of the variables associated 
with increased mammographic density allows greater understanding of the nature and 
causes ofbreast cancer. As a result, measurement of mammographic density is useful as a 
means of investigating the etiology of breast cancer and of testing hypotheses about 
potential preventive strategies. 
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Literature Review 
2.0 Literature Review 
2.1 Labisia Pumila 
Labisia pumila is a plant found in Malaysia, Thailand and Indochina (Stone, I988). It is 
synonymous with Labisia pumila Benth or Labisia pathoina Lindl and comes from plant 
genus Mysinaceae. There are 3 varieties of this plant e.g. Labisia pumila var alata, 
Labisia pumila var pumila and Labisia pumila var lanceolata. This herbaceous shrub has 
creeping rhizomes and thrives on shady areas in the tropical rain forest of Malaysia about 
80 - I 00 meters above sea level (Indu Bala jaganath, I997). This plant grows relatively 
slowly and open sunlight or even partial shade can be harmful to the growth of the plant. 
Their leaves are few about 4-I4 in numbers and more or less upright. The whole leaf is 
about 5-35cm long and 2-8cm wide. It flowers are very small, pink or white in colour (A. 
Prof Dr Zhari Ismail, I999). Figure I - 3 illustrate the plant in Malaysia. 
Herbal therapies are popular alternative to conventional therapies. Some herbs contain 
phytoestrogen which is a natural Dehydroepiandrosterone (DHEA) precursor. Examples 
of such herbs are 'Black cohosh', 'Wild Mexican Yam Root' and 'Dong quai'. These 
herbs are claimed to be effective in treating post menopausal symptoms. These herbs are 
increasingly being used because there is uncertainty and lack of consensus of standard 
estrogen replacement therapy. Women Health Initiative Study had added to the above 
confusion. In this trial, there is an increased risk of cardiovascular disease, breast cancer, 
stroke and thromboembolic events (Writing Group for the Women's Health Initiative 
Investigators, 2002). 
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Labisia pumila is also popularly known as 'Kacip Fatimah' or 'Selusoh Fatimah' by the 
Malay population. It is one of the most popular and potent ingredients used in traditional 
herbal therapy in the Malay population especially for postnatal health care, tonics for 
women and in the treatment of various gynecological disorders (Norhayati Ismail, 2005). 
It is commonly prescribed by midwives and traditional healers for various indications. It 
is given to pregnant mothers between one to two months before delivery as it is believed 
to induce and expedite labour. It is also used in postnatal care in a mixed preparation to 
help contract the birth canal, to delay fertility and to regain body strength. It is also 
commonly used for treating dysmenorrheal, venereal disease, flatulence, dysentery and 
rheumatism. The plant is often mixed with other herbs, boiled and the concoction taken 
orally. 
Many studies have been done on this herb. Two benzoquinoid compounds were isolated 
as major components from Labisia pumila alata leave and roots (P. J Houghton, 1999). 
The use of Labisia pumila in parturition suggests that it contains phytoestrogens (plant 
estrogens). The studies by Jamia et al using in vitro estrogen bioassay has shown that 
ethanol extract of L. pumila var alata was weakly estrogenic (Jamia A. Jamal, 1999). 
Studies done at Institute of Medical Research (IMR) showed that the water extract of 
Kacip Fatimah was able to displace the 17b estradiol from binding to anti-estradiol. This 
proves that the water extracts of Kacip Fatimah contain a substrate that recognizes the 
estrogen-binding moiety of the immunoglobulin raised against estradiol. Tissue culture 
experiments carried out by IMR also showed that water extract of Kacip Fatimah 
exhibited a weak but specific estrogenic effect on the human endometrial 
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adenocarcinoma cells. Therefore, it not only binds to estradiol antiserum, it also has 
estrogenic effects. 
In vitro toxicity studies have shown that Kacip Fatimah has no toxic effect on human 
cells. Julai et al exposed various cell lines including breast cancer cell lines MCF -7 and 
liver cell line WRL- 68 to various concentrations ofKacip Fatimah. In all concentrations 
tested, Kacip Fatimah has no toxic effect on the cells lines (Julai Timor, 2002). Animal 
studies on pregnant Sprague- Dawley rats has also shown that Kacip Fatimah has no 
teratogenic potential and no significant abnormal finding on the biochemistry, 
hematology and mortality of treated rats. Human studies on Kacip Fatimah have also 
been carried out by the Institute of Medical Research. One study has shown that it is safe 
for human consumption with no significant change in hematological and biochemical 
parameters (Wan Nazaimoon WM, 2002). 
-6-
Figure 1. Kacip Fatimah Plant 
These are leafy plants with leaves ranging from 
4-14 arranged in an upright position. 
Figure 2 Kacip Fatimah Flower. Figure 3 Kacip Fatimah in Jungle. 
The purple-pinkish blooms of the highland It is commonly found in shady areas of 
Kacip Fatimah found in the Gunung Beremban the jungles at elevations of 80 m to 100m. It can 
jungle in Tanah Rata, Pahang also be found in higher elevations. 
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2.2 Phytoestrogen 
Phytoestrogen is a plant substance that has varying degrees of estrogenic activity. These 
plant substances may or may not be structurally similar to gonadal estradiol 17~. There 
are three main groups of phytoestrogen e.g. isoflavones and lignans, coumestans, and 
resorcyclic acid lactones. Active isoflavones include daidzein and genistein. 
Phytoestrogens are metabolized to active forms after consumption so there may be wide 
variations in the available blood levels of any given individual. 
Major sources of phytoestrogens are soy and red clover. Labisia pumila or Kacip Fatimah 
has been shown to contain phytoestrogens. Other plants that contain phytoestrogens 
include whole grain cereals, seeds, berries and nuts (mainly lignans). The interest on 
plant estrogens has increased considerably since there is controversy about the safety of 
hormone replacement therapy. The Women's Health Initiative, a large randomized trial 
evaluating the use of HRT, demonstrated that the use of combined estrogen/progestagen 
for more than 5 years is associated with an increased risk of breast cancer, stroke and 
venous thromboembolism. As a result, phytoestrogens are becoming popular in the 
treatment of menopause. However, there is lack of scientific evidence as to whether 
phytoestrogen is effective in relieving menopausal symptoms. In the randomized placebo 
controlled trial conducted by Nikander et al to study the effect of phytoestrogens in 
treatment of menopause in breast cancer patients, pure isoflavones did not alleviate 
subjective menopausal symptoms (Nikander et al., 2003). 
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Asian countries like Japan, China and Korea have a lower incidence of breast cancer 
compared to western countries. This was attributed to the fact that Asian population 
consumed traditional diets rich in plant food especially soy product which have a higher 
dietary 'intake of phytoestrogens (Mishra et al., 2003). Vegetarian and traditional 
Japanese diets have approximately 4.5 times the amount of phytoestrogens than the 
average American diet. It has been observed that the risk of breast cancer increased after 
immigration from Asia to United States (Adlercreutz, 2002). This may be due to dietary 
changes after migration. Phytoestrogens may play a significant inhibitory role during the 
initiation and promotional phases of cancer development. It has hormone-like compounds 
that exhibit ability to bind with low affinity estrogen receptors but fail to elicit a full 
estrogenic response. A case control study was conducted by Ingram et al to investigate 
the association between phytoestrogens and human breast cancer. The result showed that 
a statistically significant reduction in breast cancer risk was associated with women who 
had a high urinary excretion over 72 hours of phytoestrogens equol and enterolactone 
(Ingram D, 2000). 
Phytoestrogens has been used and marketed as 'bust enhancing' herbal products (Pugh-
Berman, 2003). However, no clinical trials have been published so far on this matter. 
Several of these herbs contain phytoestrogen which may have effects on the breast. 
Atkinson et al showed that isoflavone supplement for a year did not increase 
mammographic breast density (Atkinson et al., 2004). 
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2.3 Mammary gland 
The mammary glands are specialized and modified accessory glands of the skin capable 
of secreting milk. The nipple is surrounded by a coloured skin area called the areola. 
Breast tissue consists of a system of ducts embedded in connective tissue. 
Mammary gland develops on the chest wall between the clavicle and the sixth to eighth 
ribs. The base of breast extends from the second to the sixth rib and from the lateral 
margin of the sternum to the midaxillary line. It gradually enlarges during puberty and 
will attain a hemispherical shape under the influence of the ovarian hormones. The ducts 
elongate and the deposition of fat increases the size of breasts. Most of the breast tissue 
lies in the superficial fascia and a small part called axillary tail extends upward and 
laterally to the axillary region by piercing the deep fascia at the lower border of the 
pectoralis major muscle. 
There are fifteen to twenty lobes in each breast. The main duct from each lobe converges 
toward the nipple and opens separately on the summit of the nipple. The base of the 
nipple is surrounded by the areola which has tiny tubercles produced by underlying 
areolar glands. The lobes of the gland are separated by fibrous septa. The breast is 
separated from the deep fascia covering the underlying muscles by an area of loose 
connective tissue known as the retromammary space. 
Mammary glands are supplied by perforating branches of the internal thoracic artery and 
the intercostal arteries. The axillary artery also supplies the gland through the lateral 
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thoracic and thoracoacromial branches. The veins correspond to the arteries. The 
lymphatic system of the breast is of clinical importance in term of cancerous spread. The 
lateral quadrants of the breast drain into the anterior axillary or pectoral nodes. The 
medial quadrants drain into the nodes along the internal thoracic artery. A few lymph 
vessels follow the posterior intercostal arteries and drain posteriorly into the posterior 
intercostal nodes. Some lymphatic vessels communicate with the lymphatic vessels of the 
opposite breast. 
2.4 Mammography. 
2.4.1 Mammogram 
A mammogram is an x ray of the breast. It is an essential part of the modern 
multidisciplinary approach to effective investigation and management of breast disease. 
The standard technique used for breast imaging is screen film mammography. It requires 
consistent high quality images with optimum film density and contrast, high resolution 
and low radiation dose. This is particularly important for the detection of small cancers 
due to subtle radiological signs. The acceptable physical criteria for optimal mammogram 
are mean optical density of 1.4 to 1.8, high contrast spatial resolution of 10 line pairs per 
mm and mean glandular dose of2 mGy per view. 
Dedicated mammography x ray equipment is necessary for producing high quality 
images. A high voltage generator should produce a near constant potential output. The 
most commonly used target filter combination is a molybdenum target with 0.03 mm Mo 
- 11 -
filter. The peak kilovoltage is normally in the range of 26- 30 kV and typically 28 kV. 
The resultant X ray spectrum exhibits characteristic x rays at 17.4 and 19.4 ke V. A small 
focal spot of0.3- 0.35 mm is necessary for high resolution in1ages. A fine focal spot of 
0.1 mm is used for magnification techniques. The focus to film distance is in the range of 
60-65 mm. 
Automatic exposure control (AEC) is used in mammography to automatically control the 
exposure duration so that the optimum optical density of the mammogram is maintained 
over a wide range of different breast sizes and densities. The AEC device is either a 
photo timer or ionization chamber. It is normally positioned 3-5 em posterior to the 
nipple because most dense glandular tissue is likely to be retroareolar. Moving grid 
system is used in mammography to improve resolution and contrast by decreasing 
scattered radiation. It is not required in magnification mammography because the scatter 
radiation is reduced by an air gap. 
Breast compression is essential to ensure high quality mammograms and is applied using 
a powered system operated by a foot control. Film compression should be. applied to the 
entire breast. The purposes of even and finn compression are to reduce dose, scatter 
radiation, geometric unsharpness, movement and tissue overlap. Single emulsion film is 
used with single intensifying screen in film screen mammography to ensure optimum 
resolution. Good film screen contact in cassettes is also important. The speed of the film 
screen combination is increased with the use of rare earth materials e.g. gadolinium 
oxysulphide. This will allow a decrease in the radiation dose while maximizing contrast. 
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Processing the mammogram is a critical part of the mammographic procedure because 
sharp, high contrast, artifact-free images are important for optimal diagnostic value. A 
dedicated processing facility is essential to ensure image quality. The chosen processing 
conditions and chemistry need to be matched to the film screen combination in use. 
Extended processing is used in mammography to obtain better contrast. The processing 
time is extended up to 3.5 minutes together with a lower developer temperature (34 
degree Celsius) to achieve optimal film density and contrast. 
2.4.2 Mammography projections. 
The standard mammography consists of a medial-lateral oblique (MLO) and crania-
caudal (CC) view of each breast. Careful positioning is essential for optimal 
demonstration of breast tissue. 
The standard CC view is obtained with a vertical x ray beam and the breast being 
compressed between the two plates horizontally. The CC view demonstrates the 
subareolar, medial and lateral portion of the breast. However, the posterolateral aspect of 
the breast may be incompletely demonstrated. 
The medial-lateral oblique view is usually obtained with the x ray tube angled between 
30 - 60 degree to the horizontal depending on the built and pectoralis muscle of the 
women. More breast tissue is demonstrated on the MLO view than any other view. The 
nipple should be in profile in MLO view. The pectoralis muscle should be visible down 
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to the level of nipple and the inframammary fold should be visible without sagging. The 
glandular tissue should be evenly compressed and adequately penetrated. There should be 
no skin folds superimposed on the breast. Patients need to be relaxed to achieve optimal 
positioning. 
Supplemental views are occasionally obtained to further evaluate breast tissue. 
Magnification views are obtained by increasing the object-film distance to product an air 
gap and a fine focal spot is used to increase resolution. A magnification factor of 1.5 is 
usual and the increased resolution obtained is particularly helpful for detailed analysis of 
microcalcification and margin of the small mass lesions. Localized compression views 
are obtained by using a small paddle compression device. This is to displace the 
overlying breast tissue so that better demonstration of the features of the lesion can be 
obtained. 
2.5 Mammographic Density 
The breast has two major components which are the fibroglandular tissue and fat on the 
basis of mammographic appearance. Fibroglandular tissue is a mixture of fibrous 
connective tissue and glandular tissue. Glandular tissue includes the epithelial cells that 
line the ducts and fibrous connective tissue includes the stroma of the breast. Fat appears 
darker on mammogram because it is more radiolucent than fibroglandular tissue. 
Fibroglandular tissue appears as radio-opaque areas and often referred as n1ammographic 
density or breast density (Byng et al., 1998). 
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There is a wide range of breast appearances on mammogram due to variation in breast 
compositions. The breast compositions of fat and fibroglandular tissue will have major 
impact on mammographic density. The fibroglandular tissue is influenced by estrogen 
level in the blood. Estrogen increases cell proliferation and progesterone enhances the 
effect. Breasts of premenopausal women will undergo cyclic changes during the 
menstrual cycle. During the follicular phase, cell proliferation increases and is further 
enhanced during the luteal phase. As a result, the breast will appear denser on 
mammogram during the luteal phase compared to the follicular phase. 
With the reduction of estrogen and progesterone levels after menopause, the lobular 
tissue regresses. As a result, the breasts will appear more radiolucent on mammogram. 
The breast will continue to become less dense in about 50% of women in their 40s and 
65% of women in their 20s have 50% or greater breast density (Stomper et al., 1996). 
2.6 Methods of measuring breast density 
2.6.1 Wolfe Classification. 
In 1976, Wolfe classified breast parenchyma on mammogram into four categories based 
on radiographic appearance (Wolfe, 1976). Wolfe parenchymal pattern is based not only 
on the extent of the densities but also on the characteristics of the densities seen 
(prominent ducts and dysplasia). The following are the description provided by Wolfe. 
Nl category refers to the parenchyma composed primarily of fat with at most small 
amounts of dysplasia and no ducts are visible. P 1 category refers to parenchyma 
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composed chiefly of fat with prominent ducts in the anterior portion up to the one-fourth 
the volume of the breast. P2 category indicates severe involvement of the breast with 
prominent ductal pattern occupying more than one-fourth the volume of breast. DY 
category refers to severe involvement with dysplasia which often obscures an underlying 
prominent ductal pattern. Nulliparous women and women with family history of breast 
cancer are those most likely to fall into the P2 and DY categories (Ernster et al., 1980). 
This classification has been applied inconsistently and has wide range of interobserver 
agreement. 
Breast density can be assessed from the mammogram film or digitized film. Jeffreys et al 
reported that density assessment from the original film and from a digitized image are 
reasonably similar but there is some evidence to suggest that the digitized image is 
assigned a higher Wolfe category and agreement using percentage categories system was 
moderately good (Jeffreys et al., 2003). 
2.6.2 Laszlo Tabar Classification 
Laszlo Tabar developed a method of classification based on anatomic-mammographic 
correlation. There are five patterns in this classification. Pattern I involve scalloped 
contours from Cooper's ligaments and evenly scattered terminal ductal lobular units 
(TDL U) as 1-2 mm nodular densities on the mammogram. There are also oval shaped 
lucent areas corresponding to fatty replacement in this pattern. Patterns II represents 
complete fatty replacement of breast. Pattern III is the combination of retroareolar 
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prominent duct pattern due to periductal elastosis and fatty involution. Pattern IV 
demonstrates extensive nodular and linear densities throughout the breast. The linear 
densities are due to periductal elastic tissue proliferation with fibrosis called 
fibroadenosis. The scattered nodular densities of 3-7 mm are due to proliferating 
glandular structures and enlarged TDLU referred as adenosis. Pattern V consists of 
homogeneous, uniformly dense parenchyma with smooth contour due to extensive 
fibrosis. In terms of risk of developing breast cancer, patterns I to III are considered as 
low risk groups and patterns IV and V are categorized into high risk group. 
Gram et al reported that the overall agreement on high risk versus low risk for Tabar and 
Wolfe classification was 55% with k value of 0.23. This indicates a poor agreement 
between these two classifications (Gram et al., 1997). The study also showed that the 
strength of association between high risk mammographic patterns and the three selected 
breast cancer risk factors e.g. parity, number of children and age at first birth, was of 
greater magnitude when the Tabar instead of the Wolfe classification was applied. Tabar 
classification also appears to be more closely related to breast cancer risk factors among 
perimenopausal women compared to Wolfe classification. 
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2.6.3 Percentage Categories 
Visual estimation of the percentage of the breast occupied by fibroglandular tissue has 
been used frequently. According to Stomper et al, parenchymal density on mammogram 
was assessed visually and was categorized as less than 10%, 1 0-49o/o, 50-89% and 90% 
or greater dense tissue. The subcutaneous and retromammary fat regions in each breast 
were excluded during the determination of dense tissue. In patient with asymmetric tissue, 
the breast with greater density was categorized. (Stomper et al., 1996) 
Boyd et al proposed a five categories systems which are <1 0%, I 0-25%, 25-50%, 50-
75% and >=75%. In this study, the reliability of this classification was assessed by 
rereading 100 images. Boyd reported intraclass correlation coefficient of 0.94 for 
repeated reading. This indicates high degree of reliability (Boyd et al., 1995). 
Wolfe's parenchymal pattern and the percentage of breast densities were each related to 
the breast cancer risk. These two classifications are not independent but instead 
substantially overlap and are highly correlated. However, according to Brisson et al, 
parenchymal pattern added little to the prediction of breast cancer risk once percent 
density was taken into account (Brisson et al., 2003). 
2.6.4 BIRADS Density Categories 
In the United States, Breast Imaging Reporting and Data System (BIRADS) is used in 
mammographic reporting to standardize mammography reporting terminology and 
recommendation categories. Density classification is also included in the BIRADS 
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reporting to inform referring physicians of the decline of sensitivity of mammography 
with increasing breast density. The four categories used in the BIRADS are almost 
entirely fatty, scattered fibroglandular densities, heterogeneous density and extremely 
dense. This is based on qualitative assessment and there is only moderate interobserver 
agreement seen with the use ofBIRADS density categories. Berget al reported an overall 
kappa value of 0.43 among observers in describing breast density (Berg et al., 2000). 
2.6.5 Computer assisted method 
Computer assisted measurement of breast density has been used recently. The 
mammographic density can be assessed quantitatively with the use of a continuous scale. 
Mammogram film is digitized and a simple observer assisted technique called interactive 
thresholding was used to measure mammographic density. This technique is easily 
applied to a digital representation of the mammogram with a personal computer 
workstation. The brightness of each pixel in the digitized image is represented by a grey 
level value in a histogram. An observer will manipulate a colour overlay to select 
threshold grey levels that helped identify the edges of density regions on a digital display 
of the image. The first threshold helps distinguish the edge of the breast from the image 
background. Then a second threshold is selected that best outlines regions of 
mammographic density on the image. Pixels above this threshold are interpreted as 
mammographic density. The total breast and density area is calculated by summing pixels 
within each region. The ratio of the total breast areas and area of mammographic density 
is the percentage of breast density. It is more consistent with less interobserver variability. 
The interobserver agreement is reported to be 90% or greater (Byng et al., 1998). 
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2.6.6 Radiographic method. 
Breast glandularity could also be determined from radiographic data e.g. tube potential 
(kV), tube loading (mAs) and compressed breast thickness. Radiographic data was 
collected by exposing different thickness of phantom material of varying glandular and 
adipose compositions at 27 kV. Then a fitted equation was derived and applied to 
calculate breast glandularity. In the study conducted by Jamal et al using this method, the 
average breast glandularity of Malaysia women was 48.9% (Jamal et al., 2004). 
2. 7 Relationship between mammographic density and breast 
cancer 
Glandular tissue of the breast is the common site for breast cancer and contributes to the 
mammographic density. It is the most vulnerable tissue among the tissues that makes up 
the breast e.g. adipose, skin and areolar tissue. The amount of glandular tissue is linked to 
breast cancer risk. So an objective analysis of glandular tissue can aid risk estimation. 
Wolfe et a1 already demonstrated a relationship between breast density and breast cancer 
risk in 1976 (Wolfe, 1976). Wolfe revealed that there was 37 times greater incidence of 
breast cancer for those at highest risk group compared to the low risk group. Some 
studies that have made use of Wolf grades confirmed that a relative risk between 2 and 4 
exists. 
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Quantitative methods have been used by many studies to report association between 
breast densities with breast cancer risk. Studies that used quantitative estimates of the 
area of density show a substantially higher odds ratio than studies using Wolfe's 
classification. In the study conducted by Brisson et al, women with >85% of the breast 
density have a >5 fold increase in risk compared with women with no density of the same 
age and body weight (Brisson et al., 2003 ). Using computer assisted interactive 
thresholding technique; Byng et al reported a 2% increase in breast cancer risk with each 
I o/o increase in breast density (Byng et al., 1998). 
Boyd et al reported a 43% increase in the relative risk between the lower and the next 
higher category of density as determined by radiologists and there was a 32% increase as 
determined by the computer assisted method (Boyd et al., 1995). He concluded that 
increases in the level of breast tissue density as assessed by mammography are associated 
with increases in risk for breast cancer. The elevated risk associated with breast densities 
persisted for at least 5 years after the mammogram used in classification had been taken. 
In this study, statistically significant increases in breast cancer risk associated with 
increasing mammographic density were higher for older than for younger women. 
The biological basis for the association of mammographic density with risk of breast 
cancer is not completely clear. There are published articles suggesting that 
mammographic density is associated with epithelial and stromal proliferation. Li et al 
analyzed breast tissue obtained at forensic autopsy and not selected from the presence of 
abnormality. Breast tissue obtained by surgical biopsy or mastectomy may give biased 
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result because the histological features of breast tissue fron1 subjects known or suspected 
of having breast disease may not be representative of all women. In the study conducted 
by Li et al, the percentage of mammographic density was associated with the proportion 
of the biopsy area occupied by nuclei, both epithelial and nonepithelial and by collagen 
and the area of glandular structures. Several breast cancer risk factors that are also 
associated with variations in mammographic density, notably body weight, parity and 
menopausal status were also associated with differences in one or more of these tissue 
features. All risk factors for breast cancer must ultimately exert their influence by an 
effect on the breast and some of these factors exert their effect through their influence on 
the number of cells and the quantity of collagen which will be reflected in 
mammographic density (Li et al., 2005). 
There is a direct relationship between mammographic density and cytological 
abnormality. Lee et al found that highly dense mammograms were associated with 
cytological atypia (Lee et al., 1994). In this study, the odds ratio of high density 
mammogram (over 50%) with nipple aspirate fluid cytological atypia was 4.4. Women 
with nipple aspirate cytological diagnoses of atypia had three times greater risk of breast 
cancer than women with normal cytology. Boyd et al reported that the risk of developing 
the epithelial lesions of atypical hyperplasia and in situ cancer, and of hyperplasia 
without atypia was greater in women aged less 50 with extensive mammographic 
densities than women with little density (Boyd et al., 2000). This finding supported the 
postulate that mammographic dense tissue indicates proliferation of breast epithelium and 
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stroma. This mechanism will lead to increased risk of those types of benign breast disease 
that confer an increased risk of breast cancer. 
If breast density is a moderate risk factor and the risk factor is fairly common, breast 
cancers attributable to increased breast density could potentially account for an important 
percentage of total breast cancer cases. In Canadian breast cancer screening study, Boyd 
et al reported that 18.6% of cancers occurred in those subjects with the most extensive 
category of density of radiologists' classification and 44.1% of the cancers occurred in 
the two most extensive categories. The attributable risk associated with dense breast is 
therefore much higher than for most risk factors for breast cancer. (Boyd et al., 1995) For 
example, family history of breast cancer is present in about 1% of breast cancer cases but 
mammographic density is much more common in women with breast cancer. Therefore 
family history (which typically has an attributable risk of 7%) has lower attributable risk 
than breast density of more than 50% (as assessed radiologically) which has a greater 
population attributable risk of approximately 30% (Cuzick et al., 2004). 
Increased parenchymal density is of greater clinical significance as a cause of false 
negative mammograms (Stomper et al., 1996). This is because it is difficult to achieve 
good contrast throughout a mammogram in women with extensive mammographically 
dense tissue. This will obscure some of the subtle signs of breast abnormalities. As a 
result, it is more difficult to diagnose breast cancer in such women (Byng et al., 1998). 
Barlow et al showed that sensitivity and specificity generally declined as breast density 
increased in diagnostic mammograms (Barlow et al., 2002). 
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Family history is one of the most well established breast cancer risk factor. A women 
with a mother or sister with breast cancer has an approximately two to threefold increase 
in risk of developing breast cancer. It has been established that approximately 7% of all 
breast cancer cases are related to inherited genes (Hulka and Moorman, 2001). The first 
breast cancer susceptibility gene BRCA I gene linked to both breast and ovarian cancer 
was identified in 1990. This gene has been associated primarily with early onset disease 
before age 50. Family history of breast cancer is also associated with breast density. Ziv 
et al reported that women with higher breast density were more likely to have first degree 
relatives with breast cancer. Thus, the genetic factors that determine breast cancer risk 
may determine breast density as well (Ziv et al., 2003). 
Other risk factors for breast cancer are parity, age, menopause status, age at menarche 
and HRT. Obesity is also a risk factor for development of breast cancer in 
postmenopausal women. This may be due to delayed detection secondary to greater 
difficulty in performing clinical examination of the larger breast of obese women. An 
increased body mass index was also associated with greater compressed breast thickness, 
resulting in increased geometric unsharpness, decreased image contrast and greater 
potential for motion unsharpness (Guest et al., 2000). This resulted in detrin1ental effect 
on mammographic image quality and lead to false negative screening mammogram. Hunt 
et al showed that increasing adiposity correlates with progressive increases in the rates of 
recall, biopsy and cancer detection for women undergoing screening mammography. 
Increasing adiposity also correlated with increased cancer size and stage (Hunt and 
Sickles, 2000). Mammographic densities are also associated with some other risk factors 
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